Medicine and Dentistry
Chimeric Antigen Receptor T-Cell
100%
Solid Malignant Neoplasm
50%
Intracellular Signaling
50%
Neoplasm
33%
Cancer Cell
33%
Cancer Stem Cell
33%
Epitope
33%
Glioblastoma
33%
T Cell Activation
33%
Chimeric Antigen Receptor
33%
T Cell
33%
Antigen
16%
Hematologic Malignancy
16%
Toxicity
16%
Development
16%
Cell Therapy
16%
Immunotherapy
16%
Antigen Specificity
16%
Glycosylation
16%
Membrane Antigen
16%
Single Chain Fragment Variable Antibody
16%
Therapeutic Procedure
16%
Researcher
16%
Tenidap
16%
Cells
16%
Recognition
16%
Organ
16%
Immunology and Microbiology
Chimeric Antigen Receptor T-Cell
100%
Solid
50%
Epitope
33%
Cancer Cell
33%
Chimeric Antigen Receptor
33%
Molecule
33%
Antigen
16%
Glycosylation
16%
Cancer Stem Cell
16%
Immunotherapy
16%
Antigen Specificity
16%
CD19
16%
Membrane Antigen
16%
Surface Property
16%
Development
16%
Cells
16%
Recognition
16%
Organ
16%
Single-Chain Variable Fragment
16%
Pharmacology, Toxicology and Pharmaceutical Science
Solid Malignant Neoplasm
50%
Clinical Trial
50%
Neoplasm
33%
Colorectal Cancer
33%
Epitope
33%
Glioblastoma
33%
Chimeric Antigen Receptor
33%
Immunotherapy
16%
Toxicity
16%
Hematologic Malignancy
16%
Antigen
16%
Membrane Antigen
16%
Tenidap
16%
Biochemistry, Genetics and Molecular Biology
Solid
50%
Molecule
33%
Cancer Cell
33%
Chimeric Antigen Receptor
33%
Cancer Stem Cell
16%
Glycosylation
16%
Surface Property
16%
Antigen Specificity
16%
Development
16%
Recognition
16%
CD19
16%
Single-Chain Variable Fragment
16%